Sanjivani Paranteral Limited (BOM:531569)

Market Cap	2.04B -31.3%
Revenue (ttm)	736.34M +13.7%
Net Income	82.71M +15.4%
EPS	6.60 +19.3%
Shares Out	12.28M
PE Ratio	25.15
Forward PE	n/a
Dividend	0.50 (0.30%)
Ex-Dividend Date	n/a

Volume	2,442
Average Volume	3,446
Open	167.50
Previous Close	167.50
Day's Range	161.00 - 167.85
52-Week Range	132.50 - 268.80
Beta	-0.34
RSI	49.60
Earnings Date	May 14, 2026

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering ...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531569

Financial Performance

In fiscal year 2025, Sanjivani Paranteral's revenue was 700.99 million, an increase of 28.83% compared to the previous year's 544.11 million. Earnings were 80.97 million, an increase of 31.34%.